Agilent Technologies, Inc. (A) vs Illumina, Inc. (ILMN)

Agilent Technologies, Inc. and Illumina, Inc. are both Diagnostics & Research companies. Agilent Technologies, Inc. is the larger, with a market value of $48.4B against $31.5B — 1.5× the size. Agilent Technologies, Inc. trades at the lower P/E: 33.8× against 35.6×. Agilent Technologies, Inc. grew revenue faster over the last twelve months: 8.60% against 5.83%. Illumina, Inc. has the higher net margin (19.7% vs 19.5%) and the higher return on invested capital (16.7% vs 11.1%). Across the 22 metrics below, Illumina, Inc. leads on 13 and Agilent Technologies, Inc. on 9.

Valuation

Metric A ILMN Diagnostics & Research median
P/E 33.77 35.62 34.52
P/S 6.58 6.98 4.24
P/B 6.58 10.07 3.42
Price to free cash flow 38.20 30.41 33.51
EV/EBITDA 26.37 26.35 23.44
EV/Sales 6.83 7.19 5.18
Earnings yield 2.96% 2.81% (1.50%)
Free cash flow yield 2.62% 3.29% 0.00%

Profitability

Metric A ILMN Diagnostics & Research median
Gross margin 53.83% 67.87% 48.32%
Operating margin 22.23% 21.18% (5.68%)
Net margin 19.53% 19.72% (4.10%)
Free cash flow margin 17.19% 23.29% 0.00%
Return on equity 20.97% 32.39% 0.00%
Return on assets 11.00% 13.78% (6.05%)
Return on invested capital 11.07% 16.70% 0.00%

Growth

Metric A ILMN Diagnostics & Research median
Revenue growth (TTM) 8.60% 5.83% 8.99%
EPS growth (last fiscal year) 3.16% 170.87% 20.36%
Revenue growth, 5-year CAGR 5.41% 6.04% 7.30%
Net income growth, 5-year CAGR 12.63% 5.32% 0.00%

Health

Metric A ILMN Diagnostics & Research median
Debt to equity 0.50 0.57 0.01
Current ratio 2.05 2.63 2.27
Net debt to EBITDA 0.71 (0.13) 0.68

Dividend

Metric A ILMN Diagnostics & Research median
Dividend yield 0.59% — 0.67%
Payout ratio 0.20 — 0.20

Size

Metric A ILMN Diagnostics & Research median
Market cap 48.43b 31.45b 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack